Abatacept as an alternative therapy for the treatment of drug-intolerant lupus nephritis: A case of underlying monosomy 1p36 deletion syndrome

Clin Nephrol. 2022 May;97(5):309-310. doi: 10.5414/CN110633.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Abatacept / therapeutic use
  • Chromosome Deletion
  • Chromosome Disorders
  • Chromosomes, Human, Pair 1
  • Female
  • Humans
  • Lupus Nephritis* / drug therapy
  • Lupus Nephritis* / genetics
  • Male
  • Monosomy

Substances

  • Abatacept

Supplementary concepts

  • Chromosome 1p36 Deletion Syndrome